Showing results (1211-1220 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|January 1, 1989
Influence of fetal calf serum in combination with pharmacological doses of progesterone or estradiol on proliferation and cell cycle kinetics of cultured mammary cancer cellsR Kiss, Y de Launoit, A Danguy, et al.
Oncology|July 21, 2012
Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective studyMarlo Blazer, Gary Phillips, Joshua Reardon, et al.
Oncology|August 15, 2012
Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trialsB Basu, J Vitfell-Pedersen, V Moreno Garcia, et al.
Oncology|January 1, 1985
Inhibitory action of aminoglutethimide on DMBA-induced mammary carcinogenesisA R Rao, M G Das, P Das
Oncology|January 1, 1985
Cis-diaminodichloroplatinum (II) chemotherapy for advanced adenocarcinoma of the upper gastrointestinal tractH Kantarjian, J A Ajani, D A Karlin
Oncology|January 1, 1990
Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: a follow-up studyS Senatore, L Zizzi, C Blasi, et al.
Oncology|January 1, 1990
Malignant pleural effusions: meaning of pleural-fluid pH determinationV Foresti, N Scolari, A Villa, et al.
Oncology|January 1, 1990
Concomitant administration of 4-hydroxypyrazolopyrimidine (allopurinol) and high-dose continuous infusion 5-fluorouracilN Tsavaris, P Karagiaouris, K Vonorta, et al.
Oncology|January 1, 1990
Coincidental papillary carcinoma of the thyroid in two sistersJ Szántó, C Gundy, K Tóth, et al.
Oncology|September 6, 2012
Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trialsDominik P Modest, Thomas Brodowicz, Sebastian Stintzing, et al.
Pageof 526